deCODE genetics (Nasdaq:DCGN) today announced that
it will webcast live the presentations at the company’s annual R&D event
being held in Reykjavik on Monday, June 26, 2006. deCODE management will
present overviews of progress in the company’s drug development, drug discovery
and genetics programs, as well as updates on finance, intellectual property
and corporate alliances. The program will begin at 9am GMT/5am Eastern Time,
and is expected to last approximately four hours.
The webcast can be accessed through the Investors page on deCODE’s website,
www.decode.com. Those interested in listening should log on a few minutes
in advance in order to download any software or complete any sign-in that
may be required. The presentations will be archived on deCODE’s website.
About deCODE
deCODE is global leader in applying human genetics to develop drugs for common
diseases. Our population approach has enabled us to discover and target key
biological pathways involved in conditions ranging from heart attack to cancer.
We are turning these discoveries into new medicine to better treat and prevent
many of the biggest challenges to public health. deCODE is delivering on the
promise of the new genetics.SM Visit us on the web at www.decode.com.
